Tüdőrák: vizsgálatok itt: Franciaország
318 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 18.. Ask the study team whether a trial fits you.
- 3. fázisNot yet taking people in FranciaországA Study to Compare Setidegrasib (ASP3082) With Docetaxel, in People With Non-small Cell Lung Cancer With a KRAS G12D Mutation
- Where
- Avignon Cedex 9, Boulogne-Billancourt, Bron, Caen Cedex 5, Caen Cedex 9, Créteil, Dijon, Le Mans Cedex 9, Lyon, Lyon Cedex 04, Marseille, Nice Cedex 2, Paris, Pessac, Pierre-Bénite, Quimper Cedex, Rennes, Saint-Herblain, Saint-Herblain Cedex, Suresnes, Valenciennes, Villefranche Sur Saone Cedex, Villejuif
- Életkor
- 18 év and over
- People
- 356 worldwide
- Run by
- Astellas Pharma Global Development, Inc.
See details and how to joinNCT07566052 · EU 2025-524079-22-00 - 1/2. fázisTaking peopleA Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)
- Where
- Lyon, Saint-Herblain, Toulouse Cedex 9, Villejuif
- Életkor
- 12 év and over
- People
- 840 worldwide
- Run by
- Nuvalent Inc.
See details and how to joinNCT05384626 · EU 2024-514266-39-00 - 3. fázisFut, nem toborozStudy of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
- Where
- Bordeaux, Brest, Bron, Creteil Cedex, Grenoble Cedex 9, Lille, Lyon, Marseille, Montpellier Cedex 5, Paris, Paris Cedex 18, Rennes Cedex 9, Saint-Herblain, Saint-Herblain Cedex, Strasbourg Cedex, Toulouse, Villejuif
- Életkor
- 18 év and over
- People
- 590 worldwide
- Run by
- Revolution Medicines, Inc.
See details and how to joinNCT06881784 · EU 2024-518154-16-00 - No phaseTaking peopleAnalysis of Circulating Tumor Markers in Blood - ALCINA 5
- Where
- Montpellier
- Életkor
- 18 év and over
- People
- 620
- Run by
- Institut du Cancer de Montpellier - Val d'Aurelle
See details and how to joinNCT07060950 - No phaseTaking peopleDevelopment of Clinical and Biological Database on Bronchial Cancer
- Where
- Montpellier
- Életkor
- 18 év and over
- People
- 750
- Run by
- Institut du Cancer de Montpellier - Val d'Aurelle
See details and how to joinNCT07085429 - 1/2. fázisNot yet taking people in FranciaországA Study of VRN110755 in Patients With EGFR-Mutant Non-Small Cell Lung Cancer
- Where
- Dijon, Marseille
- Életkor
- 18 év and over
- People
- 315 worldwide
- Run by
- Voronoi, Inc
See details and how to joinNCT07699328 · EU 2025-523122-40-00 - No phaseNot yet taking people in FranciaországPROMETHEE: A Shared Interregional Tele-Tobacco Cessation Platform Embedded Within the IMPULSION Lung Cancer Screening Program
- Where
- Pierre-Bénite
- Életkor
- 50 év to 74 év
- People
- 5400
- Run by
- Hospices Civils de Lyon
See details and how to joinNCT07921719 - 3. fázisTaking peopleA Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
- Where
- Angers, Bobigny, Bron, Caen, Lyon, Montpellier, Nice, Paris, Pessac, Reims, Saint-Quentin, Strasbourg, Vannes
- Életkor
- 18 év and over
- People
- 600 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT06793215 - 3. fázisTaking peopleFirst-line Immunotherapy-based Standard of Care and Local Ablative Treatments for Oligometastatic Non-small Cell Lung Cancer Patients.
- Where
- Avignon, Caen, Creil, Lille, Lyon, Nice, Nîmes, Paris, Saint-Cloud, Tarbes, Villejuif
- Életkor
- 18 év and over
- People
- 124
- Run by
- Gustave Roussy, Cancer Campus, Grand Paris
See details and how to joinNCT06840782 - 3. fázisTaking peopleA Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
- Where
- Bordeaux, Brest, Grenoble Cedex 9, Lille, Marseille, Nantes Cedex 1, Paris, Paris Cedex 20, Rennes, Rouen, Toulouse, Villejuif
- Életkor
- 18 év and over
- People
- 680 worldwide
- Run by
- Pfizer
See details and how to joinNCT07144280 · EU 2025-521281-97-00 - 3. fázisTaking peopleA Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)
- Where
- Bordeaux, Dijon, Lille, Limoges, Lyon, Marseille, Montpellier Cedex 5, Paris, Saint-Herblain, Toulouse, Villejuif
- Életkor
- 18 év and over
- People
- 850 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT07361497 · EU 2025-523576-23-00 - 1/2. fázisTaking peopleA Phase 1/2 Study of TRI-611 in ALK-Positive NSCLC
- Where
- Lille, Lyon, Marseille, Saint-Herblain, Villejuif
- Életkor
- 18 év and over
- People
- 160 worldwide
- Run by
- TRIANA Biomedicines, Inc.
See details and how to joinNCT07491497 · EU 2025-524418-27-00 - 1. fázisTaking peoplePhase 1 Study of PF-08046033 in Advanced Solid Tumors
- Where
- Toulouse, Villejuif
- Életkor
- 18 év and over
- People
- 250 worldwide
- Run by
- Pfizer
See details and how to joinNCT07519655 - 1/2. fázisTaking peopleA 2-part Phase 1/2 Open-label Trial on ODM-212
- Where
- Bordeaux, Marseille, Poitiers, Villejuif
- Életkor
- 18 év and over
- People
- 229 worldwide
- Run by
- Orion Corporation, Orion Pharma
See details and how to joinNCT07563738 - 3. fázisTaking peopleA Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
- Where
- Avignon Cedex 9, Bron, Lille, Lyon, Nancy, Nice Cedex 2, Paris, Pessac, Poitiers, Reims, Rennes Cedex 9, Saint-Herblain Cedex, Strasbourg Cedex, Suresnes, Toulon, Toulouse, Vantoux, Villejuif
- Életkor
- 18 év and over
- People
- 1264 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT06119581 · EU 2023-503412-33-00 - 1. fázisTaking peopleA Study of Sofe-M in Participants With Selected Advanced Solid Tumors
- Where
- Lyon, Saint-Herblain Cedex, Toulouse Cedex 9
- Életkor
- 18 év and over
- People
- 575 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT06400472 · EU 2024-511238-11-00 - 3. fázisFut, nem toborozA Study to Learn More About How Well Sevabertinib Works and How Safe it is Compared With Standard Treatment, in Participants Who Have Advanced Non-small Cell Lung Cancer (NSCLC) With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
- Where
- Bordeaux, Brest, Créteil, La Tronche, Lille, Limoges, Montpellier Cedex 5, Mulhouse, Nantes, Nice Cedex 2, Paris, Pierre-Bénite, Saint-Herblain Cedex, Suresnes, Villejuif
- Életkor
- 18 év and over
- People
- 444 worldwide
- Run by
- Bayer
See details and how to joinNCT06452277 · EU 2024-511319-91-00 - 1. fázisFelfüggesztveA Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
- Where
- Villejuif
- Életkor
- 18 év and over
- People
- 460 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT06465069 · EU 2024-512927-36-00 - 3. fázisTaking peopleStudy of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
- Where
- Bobigny, Bron, La Tronche, Lyon Cedex08, Marseille, Nice, Paris, Pessac, Poitiers, Reims, Rennes, Toulouse, Vantoux, Villejuif
- Életkor
- 18 év and over
- People
- 700 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT06890598 · EU 2024-512302-25-00 - 2. fázisTaking peopleA Study of Navlimetostat (BMS-986504) Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)
- Where
- Dijon, Paris, Pierre-Bénite, Villejuif
- Életkor
- 18 év and over
- People
- 254 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT07492680 - 3. fázisNot yet taking people in FranciaországEvaluation of the Effect of Time of Administration on the Activity on First Line of Pembrolizumab in Association With Carboplatin-pemetrexed in Metastatic Non-squamous Lung Cancer. A Randomised Multicenter Phase III Trial
- Where
- Angers, Aurillac, Bayeux, Bayonne, Bobigny, Bron, Caen Cedex 5, Créteil, Le Chesnay Rocquencourt, Lille, Marseille, Montfermeil, Paris, Rennes, Suresnes, Toulon, Villejuif
- Életkor
- 18 év and over
- People
- 254
- Run by
- Assistance Publique - Hôpitaux de Paris
See details and how to joinNCT07915037 · EU 2025-521891-78-00 - 3. fázisFut, nem toborozA Phase 3, Open-Label, Randomized, Multi-Center Study of DZD9008 versus Platinum-Based Doublet Chemotherapy as First-Line Treatment for Patients with Locally Advanced or Metastatic Non-Small Cell Lung Cancer Harboring Epidermal Growth Factor Receptor Exon 20 Insertion Mutation
- Where
- Angers Cedex 9, Bron, Créteil, Dijon, Grenoble Cedex 9, Lille, Marseille, Montpellier, Paris, Paris Cedex 18, Poitiers, Saint-Herblain, Saint-Mande, Suresnes
- Életkor
- 18 év and over
- People
- 65 worldwide
- Run by
- Dizal Pharmaceutical Co. Ltd.
See details and how to join2022-502959-54-00 - 1. fázisTaking peoplePhase I clinical trial evaluating TG4070 in patients with non-small cell lung cancer
- Where
- Marseille, Paris, Rennes Cedex 9, Strasbourg Cedex, Toulouse Cedex 9
- Életkor
- 18 év and over
- People
- 40
- Run by
- Transgene
See details and how to join2025-520946-31-00 - 2. fázisTaking peopleA Study of Amivantamab in Participants With Advanced or Metastatic Solid Tumors Including Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer
- Where
- Caen Cedex 5, Nimes Cedex 9, Paris, St Herblain, Villejuif
- Életkor
- 18 év and over
- People
- 520 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT05498428 · EU 2023-505065-91-00 - 3. fázisTaking peopleSacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab Versus Pembrolizumab Alone in Metastatic Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥ 50% (MK-2870-007)
- Where
- Amiens, Bayonne, Limoges Cedex 1, Marseille, Montpellier Cedex 5, Nancy, Poitiers, Villefranche Sur Saone Cedex
- Életkor
- 18 év and over
- People
- 614 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT06170788 · EU 2023-503376-24-00